Latest News About Lantern boosts AI-enabled growth with biopharma

Updated 2026-06-18 00:09

The Lantern is described as an AI-driven revenue tool to accelerate revenue workflows, claiming 41% better forecast accuracy and automated outreach. A Champion Agent tracks job changes across the customer base to automate outreach for certain teams. Lantern Pharma reports progress in 2026, cutting R&D spend by 47% while advancing multiple clinical programs, launching a multi-agent AI platform with Zeta.ai and expanding an AI Center of Excellence in India. These developments illustrate Lantern's growth into AI-powered drug discovery partnerships, with ongoing financing activities to support growth.

Sources

news

news

www.newswire.ca